Lysosomotropic drugs inhibit maturation of transforming growth factor-β

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 9, 2008, Pages 606-612

  Basque, Julie ^a   Martel, Marc ^a   Leduc, Richard ^a   Cantin, André M ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Convertases; Epithelial cells; Furin; Glioblastoma; Idiopathic pulmonary fibrosis; Lysosomotropic drugs

Indexed keywords

AMMONIUM CHLORIDE; AMODIAQUINE; AZITHROMYCIN; BAFILOMYCIN A1; BREFELDIN A; CHLOROQUINE; DECANOYLARGINYLVALYLLYSYLARGININE CHLOROMETHYL KETONE; FURIN; HYDROXYCHLOROQUINE; MONENSIN; PROTEIN INHIBITOR; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOSOME; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK;

EID: 50849130582     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-063     Document Type: Article

References (29)

1. Adelusi, S.A., and Salako, L.A. 1982. Tissue and blood concentrations of chloroquine following chronic administration in the rat. J. Pharm. Pharmacol. 34: 733-735. PMID:6129306.
2. Anderson, E.D., VanSlyke, J.K., Thulin, C.D., Jean, F., and Thomas, G. 1997. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 16: 1508-1518. doi:10.1093/emboj/16.7.1508. PMID:9130696.
3. Anderson, E.D., Molloy, S.S., Jean, F., Fei, H., Shimamura, S., and Thomas, G. 2002. The ordered and compartment-specific auto-proteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J. Biol. Chem. 277: 12879-12890. doi:10.1074/jbc.M108740200. PMID:11799113.
4. Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., et al. 2005. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 171: 1040-1047. doi:10.1164/rccm.200404-571OC. PMID:15665326.
5. Bassi, D.E., Fu, J., Lopez de Cicco, R., and Klein-Szanto, A.J. 2005. Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 44: 151-161. doi:10.1002/mc.20134. PMID:16167351.
6. Blobe, G.C., Schiemann, W.P., and Lodish, H.F. 2000. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342: 1350-1358. doi:10.1056/NEJM200005043421807. PMID:10793168.
7. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254. doi:10.1016/0003-2697(76)90527-3. PMID:942051.
8. Briceno, E., Reyes, S., and Sotelo, J. 2003. Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine. Neurosurg. Focus, 14: e3. doi:10.3171/foc.2003.14.2.4. PMID:15727424.
9. Burghardt, I., Tritschler, F., Opitz, C.A., Frank, B., Weller, M., and Wick, W. 2007. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem. Biophys. Res. Commun. 354: 542-547. doi:10.1016/j.bbrc. 2007.01.012. PMID:17234158.
10. Chapman, R.E., and Munro, S. 1994. Retrieval of TGN proteins from the cell surface requires endosomal acidification. EMBO J. 13: 2305-2312. PMID:8194522.
11. de Martin, R., Haendler, B., Hofer-Warbinek, R., Gaugitsch, H., Wrann, M., Schlusener, H., et al. 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 6: 3673-3677. PMID:3322813.
12. Dubois, C.M., Laprise, M.H., Blanchette, F., Gentry, L.E., and Leduc, R. 1995. Processing of transforming growth factor β1 precursor by human furin convertase. J. Biol. Chem. 270: 10618-10624. doi:10.1074/jbc.270.6.2874. PMID:7737999.
13. Dubois, C.M., Blanchette, F., Laprise, M.H., Leduc, R., Grondin, F., and Seidah, N.G. 2001. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am. J. Pathol. 158: 305-316. PMID:11141505.
14. Gauldie, J. 2002. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 165: 1205-1206. doi:10.1164/rccm.2202054. PMID:11991866.
15. Khalil, N., O'Connor, R., Unruh, H., Warren, P., Kemp, A., and Greenberg, A. 1991. Enhanced expression and immunohistochemical distribution of transforming growth factor-beta in idiopathic pulmonary fibrosis. Chest, 99(Suppl): 65S-66S. PMID:1997280.
16. Leduc, R., Molloy, S.S., Thorne, B.A., and Thomas, G. 1992. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J. Biol. Chem. 267: 14304-14308. PMID:1629222.
17. Leitlein, J., Aulwurm, S., Waltereit, R., Naumann, U., Wagenknecht, B., Garten, W., et al. 2001. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J. Immunol. 166: 7238-7243. PMID:11390472.
18. Li, L., Lok, S.M., Yu, I.M., Zhang, Y., Kuhn, R.J., Chen, J., et al. 2008. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science, 319: 1830-1834. doi:10.1126/science.1153263. PMID:18369147.
19. Massague, J., Seoane, J., and Wotton, D. 2005. Smad transcription factors. Genes Dev. 19: 2783-2810. doi:10.1101/gad.1350705. PMID:16322555.
20. Mercapide, J., Lopez De Cicco, R., Bassi, D.E., Castresana, J.S., Thomas, G., and Klein-Szanto, A.J. 2002. Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness. Clin. Cancer Res. 8: 1740-1746. PMID:12060611.
21. Ooi, E.E., Chew, J.S., Loh, J.P., and Chua, R.C. 2006. In vitro inhibition of human influenza A virus replication by chloroquine. Virol. J. 3: 39. doi:10.1186/1743-422X-3-39. PMID:16729896.
22. Perkett, E.A., Ornatowski, W., Poschet, J.F., and Deretic, V. 2006. Chloroquine normalizes aberrant transforming growth factor beta activity in cystic fibrosis bronchial epithelial cells. Pediatr. Pulmonol. 41: 771-778. doi:10.1002/ppul.20452. PMID:16779853.
23. Sheppard, D. 2006. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 3: 413-417. doi:10.1513/pats.200601-008AW. PMID:16799084.
24. Sotelo, J., Briceno, E., and Lopez-Gonzalez, M.A. 2006. Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 144: 337-343. PMID:16520474.
25. Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3: 753-766. doi:10.1038/nrm934. PMID:12360192.
26. Vey, M., Schafer, W., Berghofer, S., Klenk, H.D., and Garten, W. 1994. Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J. Cell Biol. 127: 1829-1842. doi:10.1083/jcb.127.6.1829. PMID:7806563.
27. Wick, W., Naumann, U., and Weller, M. 2006. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr. Pharm. Des. 12: 341-349. doi:10.2174/138161206775201901. PMID:16454748.
28. Xu, Y.D., Hua, J., Mui, A., O'Connor, R., Grotendorst, G., and Khalil, N. 2003. Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L527-L539. PMID:12598227.
29. Yu, I.M., Zhang, W., Holdaway, H.A., Li, L., Kostyuchenko, V.A., Chipman, P.R., et al. 2008. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science, 319: 1834-1837. doi:10.1126/science. 1153264. PMID:18369148.